shay weiss - Infectious Diseases

Author Information

Shay Weiss is affiliated with the Department of Infectious Diseases at the Israel Institute for Biological Research, located in Ness Ziona, Israel. This affiliation underscores his involvement in significant research activities related to infectious diseases, contributing to the scientific community's understanding of pathogens and viral infections.

Research Contributions

Shay Weiss has actively contributed to the field of infectious diseases, with a particular focus on viral pathogens such as SARS-CoV-2. His research includes advancements in diagnostic methodologies, like improving blood culture conditions for detecting Yersinia pestis and developing assays for SARS-CoV-2 identification. His work also spans the study of immune responses and vaccine safety, as seen in his studies on TLR3 agonists and the rVSV-ΔG-SARS-CoV-2-S vaccine. Additionally, Weiss has explored the mutation profiles of SARS-CoV-2, environmental contamination by the virus, and responses of other pathogens like Bacillus anthracis.

Aliases

No aliases were provided for Shay Weiss in the given data.

Publication and Citation Metrics

Metric	Value
Citation Count	2282
H-index	20
Paper Count	72

Publications:

An Improvement in Diagnostic Blood Culture Conditions Allows for the Rapid Detection and Isolation of the Slow Growing Pathogen Yersinia pestis

DOI: 10.3390/pathogens11020255

Year: 2022

Parsing the role of NSP1 in SARS-CoV-2 infection

DOI: 10.1101/2022.03.14.484208

Year: 2022

Neutralization of SARS-CoV-2 Variants by rVSV-ΔG-Spike-Elicited Human Sera

DOI: 10.3390/vaccines10020291

Year: 2022

Induction of Innate Immune Response by TLR3 Agonist Protects Mice against SARS-CoV-2 Infection

DOI: 10.3390/v14020189

Year: 2022

Coupling immuno-magnetic capture with LC–MS/MS(MRM) as a sensitive, reliable, and specific assay for SARS-CoV-2 identification from clinical samples

DOI: 10.1007/s00216-021-03831-5

Year: 2022

Preliminary nonclinical safety and immunogenicity of an rVSV-ΔG-SARS-CoV-2-S vaccine in mice, hamsters, rabbits and pigs

DOI: 10.1007/s00204-021-03214-w

Year: 2022

Development of an immunofluorescence assay for detection of SARS-CoV-2

DOI: 10.1007/s00705-022-05392-z

Year: 2022

Alternate response of Bacillus anthracis atxA and acpA to serum, HCO3- and CO2

DOI: 10.1101/2022.02.21.481328

Year: 2022

Revisiting SARS-CoV-2 environmental contamination by patients with COVID-19: The Omicron variant does not differ from previous strains

DOI: 10.1016/j.ijid.2022.03.001

Year: 2022

Mutation Profile of SARS-CoV-2 Genome Sequences Originating from Eight Israeli Patient Isolates

DOI: 10.1128/MRA.01387-20

Year: 2021

Which Infections Are Most Affected?

What are the treatment options for HIV?

What are the Key Components of HTS?

How is Zika Virus Transmitted?

How Do Viruses Cause Respiratory Symptoms?

How Does the NIH Contribute to Infectious Disease Research?

What Role Do Extreme Weather Events Play?

How Can HSV Be Prevented?

How Can Co-Infections Be Prevented?

What are the Challenges?

Partnered Content Networks

Relevant Topics